您的位置: 首页 > 农业专利 > 详情页

CANCER-TREATING PHARMACEUTICAL COMPOSITION INHIBITING EXPRESSION OF CCND3 OR PAK2 GENE
专利权人:
KOREA INSTITUTE OF RADIOLOGICAL &; MEDICAL SCIENCES
发明人:
Kyung Hee Koo,Hee Chung Kwon,Jie Young Song
申请号:
US16346078
公开号:
US20190256857A1
申请日:
2017.12.21
申请国别(地区):
US
年份:
2019
代理人:
摘要:
A substance inhibiting the expression of CCND3 gene or PAK2 gene, the substance containing a nucleotide such as miR-4779, may be efficiently used for preventing or treating cancer. In addition, by screening the substance that inhibits the expression of CCND3 gene or PAK2 gene, a candidate substance for preventing or treating cancer may be selected.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充